DRUG DISCOVERY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND ARRAY BIOPHARMA INC.Drug Discovery Collaboration Agreement • February 2nd, 2004 • Array Biopharma Inc • Services-medical laboratories • New York
Contract Type FiledFebruary 2nd, 2004 Company Industry JurisdictionThis Drug Discovery Collaboration Agreement (“Agreement”) is made and entered into, effective as of December 22, 2003 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • February 2nd, 2004 • Array Biopharma Inc • Services-medical laboratories • New York
Contract Type FiledFebruary 2nd, 2004 Company Industry JurisdictionTHIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is made effective as of the 18th day of December, 2003 (“Effective Date”) by and between Array BioPharma Inc., a Delaware corporation of 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), and AstraZeneca AB, a company incorporated in Sweden under no. 556011-7482 with offices at S-151 85 Södertälje, Sweden (“AZ”). Array and AZ are each referred to herein by name or as a “Party” or, collectively, as “Parties”.